Rice Bran Peptides Show Blood Pressure-Lowering Potential Through ACE Inhibition

Peptides derived from rice bran protein demonstrate anti-hypertensive effects primarily through ACE inhibition, adding plant-based options to the food-derived blood pressure management toolkit.

Shobako, Naohisa et al.·Nutrients·2020·Moderate EvidenceReview
RPEP-05134ReviewModerate Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
N=not applicable
Participants
Review article (no study population)

What This Study Found

Rice bran-derived peptides demonstrate anti-hypertensive activity primarily through ACE inhibition, with evidence from both in vitro and animal studies.

Key Numbers

Multiple ACE-inhibitory peptides identified from rice bran protein hydrolysates

How They Did This

Literature review of rice bran protein hydrolysis, identification of ACE-inhibitory peptides, and their anti-hypertensive effects in preclinical models.

Why This Research Matters

Hypertension affects over 1 billion people. Food-derived ACE-inhibitory peptides could provide a natural, side-effect-free approach to blood pressure management, especially using an abundant waste product like rice bran.

The Bigger Picture

This work expands the plant-based anti-hypertensive peptide portfolio beyond soy, showing that rice processing waste — produced in enormous quantities globally — could be a source of functional food ingredients.

What This Study Doesn't Tell Us

Review format. Most evidence from in vitro and animal studies. Human clinical trials with rice bran peptides for blood pressure are limited. Bioavailability after oral ingestion needs characterization.

Questions This Raises

  • ?Would rice bran peptide supplements produce clinically meaningful blood pressure reductions in humans?
  • ?How do rice bran ACE-inhibitory peptides compare in potency to milk-derived peptides?
  • ?Can rice bran peptides survive digestion and reach the bloodstream intact?

Trust & Context

Key Stat:
Rice waste to heart health Rice bran — a byproduct of rice processing — yields peptides that inhibit ACE and lower blood pressure in animal studies
Evidence Grade:
Moderate — comprehensive review of growing preclinical evidence, but limited human clinical data for rice bran-specific peptides.
Study Age:
Published in 2020; food-derived anti-hypertensive peptides continue to gain commercial interest.
Original Title:
Anti-Hypertensive Effects of Peptides Derived from Rice Bran Protein.
Published In:
Nutrients, 12(10) (2020)
Database ID:
RPEP-05134

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

How do food peptides lower blood pressure?

Some food peptides inhibit ACE (angiotensin-converting enzyme), the same target as prescription ACE inhibitor drugs like lisinopril. By blocking ACE, these peptides help relax blood vessels and reduce blood pressure naturally.

Is rice bran a good source of protein?

Yes — rice bran contains 12-16% protein with a high protein efficiency ratio. It is an abundant waste product from rice milling, making it a cost-effective and sustainable source for bioactive peptide production.

Read More on RethinkPeptides

Cite This Study

RPEP-05134·https://rethinkpeptides.com/research/RPEP-05134

APA

Shobako, Naohisa; Ohinata, Kousaku. (2020). Anti-Hypertensive Effects of Peptides Derived from Rice Bran Protein.. Nutrients, 12(10). https://doi.org/10.3390/nu12103060

MLA

Shobako, Naohisa, et al. "Anti-Hypertensive Effects of Peptides Derived from Rice Bran Protein.." Nutrients, 2020. https://doi.org/10.3390/nu12103060

RethinkPeptides

RethinkPeptides Research Database. "Anti-Hypertensive Effects of Peptides Derived from Rice Bran..." RPEP-05134. Retrieved from https://rethinkpeptides.com/research/shobako-2020-antihypertensive-effects-of-peptides

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.